| Secondary |
| Drug Use For Unknown Indication |
28.1% |
| Nasopharyngitis |
8.8% |
| Product Used For Unknown Indication |
8.8% |
| Upper Respiratory Tract Inflammation |
7.3% |
| Rheumatoid Arthritis |
6.9% |
| Acute Tonsillitis |
4.6% |
| Pyrexia |
4.6% |
| Hepatitis C |
3.5% |
| Cough |
3.1% |
| Bronchitis |
2.7% |
| Depression |
2.7% |
| Hypertension |
2.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.7% |
| Constipation |
2.3% |
| Non-small Cell Lung Cancer |
2.3% |
| Rosacea |
2.3% |
| Insomnia |
1.9% |
| Angina Pectoris |
1.5% |
| Diabetes Mellitus |
1.5% |
| Gastritis |
1.5% |
|
| Vomiting |
11.9% |
| Eosinophilia |
9.5% |
| Wheezing |
9.5% |
| Liver Disorder |
7.1% |
| Toxic Epidermal Necrolysis |
7.1% |
| Acquired Haemophilia With Anti Fviii, Xi, Or Xiii |
4.8% |
| Granulocytopenia |
4.8% |
| Oedema |
4.8% |
| Parkinsonism |
4.8% |
| Retinal Detachment |
4.8% |
| Retinal Haemorrhage |
4.8% |
| Stevens-johnson Syndrome |
4.8% |
| White Blood Cell Count Increased |
4.8% |
| Arthralgia |
2.4% |
| Beta Haemolytic Streptococcal Infection |
2.4% |
| Bile Duct Cancer |
2.4% |
| Cerebral Infarction |
2.4% |
| Hepatic Enzyme Increased |
2.4% |
| Hepatic Function Abnormal |
2.4% |
| Loss Of Consciousness |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.8% |
| Rheumatoid Arthritis |
21.4% |
| Prophylaxis |
11.4% |
| Drug Use For Unknown Indication |
8.8% |
| Hypertension |
3.8% |
| Gastritis |
2.8% |
| Aplastic Anaemia |
2.7% |
| Insomnia |
2.5% |
| Hiv Infection |
2.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.5% |
| Fabry's Disease |
2.3% |
| Constipation |
2.3% |
| Infection Prophylaxis |
2.2% |
| Gastric Ulcer |
1.7% |
| Osteoporosis |
1.6% |
| Gastritis Prophylaxis |
1.5% |
| Adverse Event |
1.3% |
| Premedication |
1.3% |
| Crohn's Disease |
1.2% |
| Back Pain |
1.2% |
|
| Pyrexia |
12.9% |
| Cerebral Infarction |
8.9% |
| Vomiting |
8.6% |
| Interstitial Lung Disease |
6.1% |
| Subarachnoid Haemorrhage |
5.7% |
| White Blood Cell Count Decreased |
5.4% |
| Rash |
5.0% |
| Liver Disorder |
4.6% |
| Renal Failure |
4.6% |
| White Blood Cell Count Increased |
4.3% |
| Pneumonia |
3.9% |
| Renal Impairment |
3.9% |
| Sepsis |
3.9% |
| Speech Disorder |
3.6% |
| Hepatic Function Abnormal |
3.2% |
| Rectal Cancer |
3.2% |
| Rheumatoid Arthritis |
3.2% |
| Tachycardia |
3.2% |
| Osteonecrosis |
2.9% |
| Prostate Cancer |
2.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
61.9% |
| Oral Candidiasis |
14.3% |
| Cardiac Failure Congestive |
9.5% |
| Atrial Fibrillation |
4.8% |
| Gastroenteritis |
4.8% |
| Hypercholesterolaemia |
4.8% |
|
|
